ÂÜÀòÂÒÂ×

John H. Brown is a co-founder and president of Verndari, Inc., a pre-clinical stage biopharmaceutical company based in Napa, California, that aims to transform global health through next generation vaccine science.

Mr. Brown previously served as president, Europe, Middle East and Africa region, for Bausch & Lomb, a company at the forefront of visionary innovations in eye health care. He oversaw the company’s surgical, pharma and vision care sectors, representing more than $2.5 billion in annual sales.

From 2002 to 2007, Mr. Brown was chief executive officer of Integrated Biosystems, Inc., a manufacturer of production equipment for biopharmaceutical customers including Genentech and Amgen. The company, based in Napa, California, was sold to Stedim, SA in 2004.

Mr. Brown served as CEO of Covance Biotechnology Services, Inc. (CBSI), a company based in Research Triangle Park, North Carolina, and leading in the development and manufacturing of innovative biopharmaceutical substances. CBSI, a subsidiary of Covance, Inc., was later sold to Azko Nobel.

He was co-head of Hamblet & Hayes Co., from 1971 to 1980, which was purchased by CIBA-Geigy. At CIBA-Geigy (later merged with Sandoz to become Novartis AG), Mr. Brown held various senior management roles, including senior vice president of Pharma, head of worldwide sales and marketing for Specialty Chemicals, and member of the Divisional World Managing Committee.

Mr. Brown received a B.S.E. with high honors from Princeton University in 1968 and received a M.B.A. in Finance from Harvard Business School in 1970.